BackCoherus Biosciences Overview

Coherus Biosciences Other Income Expense Net

Other Income/Expense Net for CHRS.

Quarterly Other Income/Expense

-$784000.00
↑ 60.06% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

-$2.41M
↑ 66.46% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin